News & Updates

Investigational drug for paediatric congenital adrenal hyperplasia succeeds in phase III trial

14 Sep 2024 by

The novel oral corticotropin-releasing factor type 1 receptor antagonist crinecerfont helps supress androstenedione levels in children with congenital adrenal hyperplasia (CAH) and reduce the need for glucocorticoids, as shown in the phase III CAHtalyst Pediatric trial.

Investigational drug for paediatric congenital adrenal hyperplasia succeeds in phase III trial

14 Sep 2024

Bedtime screen use harms sleep in youths

14 Sep 2024

Using screens once already in bed appears to have a negative impact on sleep in young people, especially when screen time involves gaming or multitasking, according to a study.

Bedtime screen use harms sleep in youths

14 Sep 2024

Nirsevimab cuts risk of hospitalization for RSV-associated bronchiolitis

12 Sep 2024 by

The ENVIE* study demonstrates the real-world effectiveness of nirsevimab against hospitalization for bronchiolitis associated with respiratory syncytial virus (RSV) among infants <12 months of age in France.

Nirsevimab cuts risk of hospitalization for RSV-associated bronchiolitis

12 Sep 2024

Early diagnosis, antifungal therapy improve outcomes in invasive fungal sinusitis

11 Sep 2024

Children with invasive fungal sinusitis may benefit from early diagnosis, aggressive surgical intervention, and combined antifungal therapy to achieve better outcomes, suggests a study.

Early diagnosis, antifungal therapy improve outcomes in invasive fungal sinusitis

11 Sep 2024

Sulfamethoxazole-trimethoprim plus rifampicin most used treatment for brucellosis

10 Sep 2024

In the treatment of children with brucellosis, the most prescribed antibiotic therapy is sulfamethoxazole-trimethoprim plus rifampicin, reports a study.

Sulfamethoxazole-trimethoprim plus rifampicin most used treatment for brucellosis

10 Sep 2024

Pyomyositis a challenging diagnosis in nontropical countries

09 Sep 2024 by

Diagnosis of pyomyositis, a bacterial muscle infection, among hospitalized children and adolescents with musculoskeletal pain remains difficult for many clinicians and requires greater awareness, according to a recent study.

Pyomyositis a challenging diagnosis in nontropical countries

09 Sep 2024

Birth month predicts severe RSV infection in infants

08 Sep 2024 by

Infants born prior to or within the early weeks of a respiratory syncytial virus (RSV) epidemic must be prioritized to prevent the development of a clinical severe infection, suggests a study that used machine-learning algorithms.

Birth month predicts severe RSV infection in infants

08 Sep 2024

Tapinarof safe, efficacious for moderate-to-severe AD in children, adults

06 Sep 2024 by

Treatment with tapinarof cream 1% once daily demonstrates significant efficacy with a favourable safety profile among adults and children with moderate-to-severe atopic dermatitis (AD), a study has shown.

Tapinarof safe, efficacious for moderate-to-severe AD in children, adults

06 Sep 2024

Dupilumab prevents atopic march progression in children with AD

06 Sep 2024

Use of dupilumab effectively lowers the risk of atopic march progression as opposed to conventional immunomodulatory therapies in paediatric patients with atopic dermatitis (AD), reports a recent study.

Dupilumab prevents atopic march progression in children with AD

06 Sep 2024

Paediatric T2DM: Prevalence of microalbuminuria doubles within 2 years of diagnosis

06 Sep 2024 by

Data from the Hong Kong Childhood Diabetes Registry (HKCDR) show that 2 years after diagnosis of paediatric type 2 diabetes mellitus (T2DM), approximately 20–65 percent of patients have ≥1 of the following: microalbuminuria (MA), suboptimal glycaemic control, hypertension, or dyslipidaemia.

Paediatric T2DM: Prevalence of microalbuminuria doubles within 2 years of diagnosis

06 Sep 2024

News & Updates

Filter by Specialty:

Specialty:

Investigational drug for paediatric congenital adrenal hyperplasia succeeds in phase III trial

Investigational drug for paediatric congenital adrenal hyperplasia succeeds in phase III trial

Bedtime screen use harms sleep in youths

Bedtime screen use harms sleep in youths

Nirsevimab cuts risk of hospitalization for RSV-associated bronchiolitis

Nirsevimab cuts risk of hospitalization for RSV-associated bronchiolitis

Early diagnosis, antifungal therapy improve outcomes in invasive fungal sinusitis

Early diagnosis, antifungal therapy improve outcomes in invasive fungal sinusitis

Sulfamethoxazole-trimethoprim plus rifampicin most used treatment for brucellosis

Sulfamethoxazole-trimethoprim plus rifampicin most used treatment for brucellosis

Pyomyositis a challenging diagnosis in nontropical countries

Pyomyositis a challenging diagnosis in nontropical countries

Birth month predicts severe RSV infection in infants

Birth month predicts severe RSV infection in infants

Tapinarof safe, efficacious for moderate-to-severe AD in children, adults

Tapinarof safe, efficacious for moderate-to-severe AD in children, adults

Dupilumab prevents atopic march progression in children with AD

Dupilumab prevents atopic march progression in children with AD

Paediatric T2DM: Prevalence of microalbuminuria doubles within 2 years of diagnosis

Paediatric T2DM: Prevalence of microalbuminuria doubles within 2 years of diagnosis